SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-070107
Filing Date
2018-11-27
Accepted
2018-11-27 16:29:32
Documents
11
Period of Report
2018-11-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-40738_18k.htm 8-K 24515
2 EX-99.1 a18-40738_1ex99d1.htm EX-99.1 16075
3 EX-99.2 a18-40738_1ex99d2.htm EX-99.2 11592
4 GRAPHIC g407381mmi001.jpg GRAPHIC 4051
5 GRAPHIC g407381moi001.gif GRAPHIC 125656
6 GRAPHIC g407381moi002.gif GRAPHIC 119176
7 GRAPHIC g407381moi003.gif GRAPHIC 100091
8 GRAPHIC g407381moi004.gif GRAPHIC 105265
9 GRAPHIC g407381moi005.gif GRAPHIC 76928
10 GRAPHIC g407381moi006.gif GRAPHIC 67377
11 GRAPHIC g407381moi007.gif GRAPHIC 113965
  Complete submission text file 0001104659-18-070107.txt   1035816
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 181203338
SIC: 2834 Pharmaceutical Preparations